<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02282501</url>
  </required_header>
  <id_info>
    <org_study_id>Odu-4</org_study_id>
    <nct_id>NCT02282501</nct_id>
  </id_info>
  <brief_title>Leptin and Ghrelin in ICU</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>özgür yağan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>T.C. ORDU ÜNİVERSİTESİ</source>
  <brief_summary>
    <textblock>
      Enteral alimentation is the preferred modality of support in critical patients who have
      acceptable digestive function and are unable to eat orally, but the advantages of continuous
      versus intermittent administration are surrounded by controversy.

      This prospective, randomised study was designed to compare two enteral feeding methods with
      respect to changes in levels of leptin and ghrelin in ICU.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2014</start_date>
  <completion_date type="Actual">February 2016</completion_date>
  <primary_completion_date type="Actual">October 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline in serum leptin concentration at three weeks in ICU</measure>
    <time_frame>first, 7th, 14th and 21th day</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline in serum ghrelin concentration at three weeks in ICU</measure>
    <time_frame>first, 7th, 14th and 21th day in ICU</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Critically Ill</condition>
  <arm_group>
    <arm_group_label>intermittent feeding</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Bolus infusion - The total daily feeding period was also 4-6 times a day.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>continuous feeding</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Continuous infusion - The daily desired amount was offered continuously for 20 hours a day.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>enteral feeding by nasogastric tube.</intervention_name>
    <description>method of administration enteral feeding by nasogastric tube.</description>
    <arm_group_label>intermittent feeding</arm_group_label>
    <arm_group_label>continuous feeding</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  who were unable to ingest an oral diet

          -  given decision on enteral feeding

        Exclusion Criteria:

          -  Carcinomatosis

          -  irreversible coma

          -  death or discharge before 14 days of observation

          -  contraindication to enteral feeding

          -  intolerance to the prescribed nutrients or infusion regimen

          -  burn

          -  multiple trauma

          -  morbid obesity

          -  end stage liver or renal or lung disease

          -  severe sepsis or septic shock

          -  patients with percutaneous endoscopic gastrostomy

          -  immunosuppressive drug use

          -  severe hemodynamic instability

          -  massive blood transfusion
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Anesthesiology and Reanimation Dept. Ordu University Training and Research Hospital</name>
      <address>
        <city>Altınordu</city>
        <state>Ordu</state>
        <zip>52100</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>March 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 30, 2014</study_first_submitted>
  <study_first_submitted_qc>November 3, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 4, 2014</study_first_posted>
  <last_update_submitted>March 28, 2016</last_update_submitted>
  <last_update_submitted_qc>March 28, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 29, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>T.C. ORDU ÜNİVERSİTESİ</investigator_affiliation>
    <investigator_full_name>özgür yağan</investigator_full_name>
    <investigator_title>MD, assistant professor</investigator_title>
  </responsible_party>
  <keyword>leptin levels</keyword>
  <keyword>ghrelin levels</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Critical Illness</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

